IGSF9 and metastatic malignant neoplasm in the lymph nodes: Notably, low IGSF9 expression was significantly correlated with lymph node metastasis (P = 0.023) and advanced TNM (tumor-node-metastasis) staging (P = 0.030), but not age, tumor size or tumor differentiation (Table 1).